Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy
PLOS ONE · 03.02.2023 · 18 (2) · e0274060
DOI: 10.1371/journal.pone.0274060 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 03.02.2023. Verfasst von Trinita K Barboza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: Lipidoses, Lizards. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Guelph - Ontario Veterinary College - Pet Trust Foundation.
Abstract (Originalsprache)
Objectives
To evaluate the association between plasma metabolites, biochemical analytes, diagnostic imaging findings, and the histologic diagnosis of hepatic lipidosis in bearded dragons. To assess the effects of gemfibrozil therapy on hepatic lipid accumulation and associated diagnostic tests. Animals Fourteen bearded dragons ( Pogona vitticeps) with varying severity of hepatic lipid accumulation (with and without hepatic lipidosis) were included. Procedures Animals underwent coelomic ultrasound, computed tomography (CT) scans, and coelioscopic hepatic biopsies. Clinical pathology tests included lipidologic tests, hepatic biomarkers, and mass spectrometry-based metabolomics. Animals were medicated with gemfibrozil 6mg/kg orally once a day for 2 months in a randomized blinded clinical trial prior to repeating previous diagnostic testing.
Results
Hounsfield units on CT were negatively associated with increased hepatic vacuolation, while ultrasound and gross evaluation of the liver were not reliable. Beta-hydroxybutyric-acid (BHBA) concentrations were significantly associated with hepatic lipidosis. Metabolomics and lipidomics data found BHBA and succinic acid to be potential biomarkers for diagnosing hepatic lipidosis in bearded dragons. Succinic acid concentrations were significantly lower in the gemfibrozil treatment group. There was a tendency for improvement in the biomarkers and reduced hepatic fat in bearded dragons with hepatic lipidosis when treated with gemfibrozil, though the improvement was not statistically significant.
Conclusions
These findings provide information on the antemortem assessment of hepatic lipidosis in bearded dragons and paves the way for further research in diagnosis and treatment of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
- Health Sciences Center, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
ORCID-Profile: Trinita K Barboza, Leonardo Susta, Hugues Beaufrère
Förderung
- University of Guelph - Ontario Veterinary College - Pet Trust Foundation
Zitieren
APA
Barboza, T. K., Susta, L., Zur Linden, A., Gardhouse, S., & Beaufrère, H. (2023). Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy. PLOS ONE, 18(2), e0274060. https://doi.org/10.1371/journal.pone.0274060
Vancouver
Barboza TK, Susta L, Zur Linden A, Gardhouse S, Beaufrère H. Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy. PLOS ONE. 2023;18(2):e0274060. doi:10.1371/journal.pone.0274060
BibTeX
@article{Barboza2023,
author = {Barboza, Trinita K and Susta, Leonardo and Zur Linden, Alex and Gardhouse, Sara and Beaufrère, Hugues},
title = {Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {2},
pages = {e0274060},
doi = {10.1371/journal.pone.0274060}
}
EUVIMED